An Optional Investigation of Biomarkers of Efficacy

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Rhinoconjunctivitis
Trial Locations (1)

M9C 4Z5

Topstone Research, Toronto

All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Topstone Research

UNKNOWN

lead

Circassia Limited

INDUSTRY

NCT01949415 - An Optional Investigation of Biomarkers of Efficacy | Biotech Hunter | Biotech Hunter